PET imaging before radiation not ideal for determining boost radiation doses

Nov 03, 2009

(PHILADELPHIA) Positron emission tomography (PET) imaging of non-small cell lung cancer prior to receiving radiation therapy should not be the basis for determining areas that may benefit from higher doses of radiation, according to research presented by investigators at Thomas Jefferson University Hospital at the 51st ASTRO Annual Meeting (Abstract #2583/B-186).

Some studies suggest that areas that have the highest amount of hypermetabolic activity on PET scan before treatment are the areas most likely to have increased activity after treatment, according to Nitin Ohri, M.D., a resident in Oncology at Thomas Jefferson University Hospital. Dr. Ohri analyzed this theory in the Jefferson patient population.

"Investigators are looking to PET imaging find ways to predict if any part of the tumor would benefit from a higher radiation dose," Dr. Ohri said. "I wanted to see if residual activity on a scan after treatment correlates with the activity pattern on a scan done before treatment."

Dr. Ohri looked at the PET scans of 43 patients, of which 15 had significant activity on the scans both before and after treatment. He set up a coordinate system that divided tumors into nine regions or 17 regions for larger tumors. He then correlated the activity in the regions both before and after treatment.

He found that in some patients, the activity pattern was in similar regions before and after treatment. However, there were some patients who showed activity in completely different areas after treatment than there was before treatment.

"It's not sufficient to increase the dose to areas that are especially active on PET imaging before treatment and expect that to improve the control rate," Dr. Ohri said. "It may be more appropriate to do a scan halfway through treatment and plan additional radiation dose around that."

Source: Thomas Jefferson University (news : web)

Explore further: New breast cancer screening analysis confirms biennial interval optimal for average risk women

Related Stories

One scan per patient is not always enough

Oct 19, 2009

Seven medical imaging groups wrote a joint letter to the Centers for Medicare and Medicaid Services (CMS) to formally request coverage of two fluorodeoxyglucose (FDG) positron emission tomography (PET) scans for a patient ...

New scans improve treatment accuracy

Sep 14, 2006

Australian doctors say they have developed new scans that can that quickly show whether breast cancer cells are responding to therapy.

Recommended for you

HLA expression tied to penile cancer outcomes

10 hours ago

(HealthDay)—Human leukocyte antigen (HLA) expression appears to be tied to clinical outcomes in penile cancer, according to a study published in the April issue of The Journal of Urology.

Study points to potential new lung cancer therapy

11 hours ago

New findings about regulation of PD-L1, a protein that allows cancer to evade the immune system, has shown therapeutic promise for several cancers, including the most common form of lung cancer.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.